プロピルパラベンはPI3K-mTOR経路を通じてゼブラフィッシュの筋肉の発達を阻害する
Yong Huang1, Runhao Zhu2, Yan Lei3
1State Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, Jiangxi 330000, China.
Ecotoxicology and environmental safety
|September 2, 2025
まとめ
プロピルパラベン (PP) 曝露は,鍵となるミオジェニック因子とPI3K- mTOR経路を阻害することで,ゼブラフィッシュの筋肉の発達と機能を損なう. この経路の復元は,先天性筋病における保存剤による筋肉の毒性を軽減する可能性があります.
科学分野:
- 筋肉生物学
- 毒理学について
- 発達生物学
背景:
- 生まれつきの筋肉疾患は 遺伝的な筋肉疾患です
- 環境に含まれる毒素は これらの状態を悪化させる可能性があります
- プロピルパラベンの (PP) 筋肉の毒性は十分に理解されていません.
研究 の 目的:
- PPの筋肉毒性のメカニズムを調査する.
- Tg (-1.9mylpfa: EGFP) のゼブラフィッシュモデルを使用する.
- 筋肉の発達と行動に対する PPの影響を調べる
主な方法:
- ゼブラフィッシュの画像と行動分析
- 定量PCR (qPCR) と in situ ハイブリデーション
- PI3K-mTOR経路とROSレベルを評価する
主要な成果:
- PPは筋肉繊維と前駆体細胞の発達を妨げました
- 幼虫の運動と能力の低下
- PPはMyoD,Myf5,PI3K- mTOR経路を阻害し,ROSを増加させた.
- mTORアクティベーターは PP誘発の毒性を回復させた.
結論:
- PPは,MyoD/ Myf5抑制とPI3K- mTOR抑制によって筋肉の毒性を誘発する.
- 環境保護剤は 遺伝的な筋肉障害を悪化させる可能性があります
- PI3K-mTOR経路をターゲットにすることで 治療の可能性が生まれます
関連する概念動画
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


